A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152
Source: Headache - Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research
More News: Brain | Cholesterol | Clinical Trials | Databases & Libraries | Headache | Hormones | Magnesium | Men | Migraine | Neurology | Neuroscience | Pain | Science